-
公开(公告)号:EP1727533A1
公开(公告)日:2006-12-06
申请号:EP05723530.1
申请日:2005-02-24
IPC分类号: A61K31/16
CPC分类号: A61K31/00 , A61K31/196 , A61K31/47
摘要: The instant invention provides a method for treating and/or reducing the risk for atherosclerosis, pulmonary fibrosis and stroke, comprising administering an effective amount of a cysteinyl leukotriene 2 receptor antagonist, including a selective cysteinyl leukotriene 2 receptor antagonist and a dual cysteinyl leukotriene 1 receptor and cysteinyl leukotriene 2 receptor antagonist to a patient in need of such treatment.